FTI
REGN icon

Fiduciary Trust International’s Regeneron Pharmaceuticals REGN Stock Holding History

Fiduciary Trust International’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$337K Hold
540
– – 0.06% 111
2020
Q1 		$264K Buy
+540
New +$223K 0.05% 130
2019
Q1 		– Sell
-5
Closed -$2K – 480
2018
Q4 		$2K Buy
+5
New +$1.83K ﹤0.01% 547

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fiduciary Trust International's REGN Position: Q2 2020 in Review

Fiduciary Trust International held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2020 at 540 shares worth $337K. The position accounts for 0.06% of the portfolio, ranked #111.

Fiduciary Trust International first reported a position in REGN in Q4 2018 and has held it in 3 quarters since. 932 funds tracked by Wall St. Rank hold REGN as of Q2 2020.

  • Fiduciary Trust International held 540 shares of Regeneron Pharmaceuticals worth $337K as of Q2 2020.
  • Fiduciary Trust International left its Regeneron Pharmaceuticals share count unchanged in Q2 2020.
  • Regeneron Pharmaceuticals made up 0.06% of Fiduciary Trust International's portfolio in Q2 2020, its #111 holding.
  • Fiduciary Trust International first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 3 quarters since.
  • 932 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2020.

Based on Fiduciary Trust International's 13F filing for Q2 2020, filed 11 Aug 2020.